Publications - 'F'
Publications 551 - 575 de 1212
Titre | DOI |
---|---|
Fiscal policy and national saving in emerging Asia: challenge or opportunity? D.T. Bui 2018 |
10.1007/s40822-018-0092-6 |
Fiscal Sustainability in Central and Latin America Countries: Evidence from a Panel Cointegration Approach E. Christophe; M. Llorca 2017 |
|
Fiscal Sustainability in Central and Latin America Countries: Evidence from a Panel Cointegration Approach E. Christophe; M. Llorca 2017 |
|
Fisetin yeast-based bio-capsules via osmoporation: effects of process variables on the encapsulation efficiency and internalized fisetin content ; S. Dupont; L. Beney; P. Gervais; A. Rosenthal; R.Targino Pi Correia; M.Regina da Pedrini 2016 |
10.1007/s00253-016-7425-8 |
Fisetin yeast-based bio-capsules via osmoporation: effects of process variables on the encapsulation efficiency and internalized fisetin content (vol 100, 2016) ; S. Dupont; L. Beney; P. Gervais; A. Rosenthal; R.Targino Pi Correia; M.Regina da Pedrini 2016 |
10.1007/s00253-016-7485-9 |
Fish mortality: from several inquiries to different rivers S. Calla 2017 |
10.4000/developpementdurable.11549 |
Fisher dispersion index for multivariate count distributions: A review and a new proposal C.C. Kokonendji; P. Puig 2018 |
10.1016/j.jmva.2017.12.010 |
Fisheye-Based Method for GPS Localization Improvement in Unknown Semi-Obstructed Areas J. Moreau; S. Ambellouis; Y. Ruichek 2017 |
10.3390/s17010119 |
Fistula Plug in Fistulising Ano-Perineal Crohn's Disease: a Randomised Controlled Trial A. Senejoux; L. Siproudhis; L. Abramowitz; N. Munoz-Bongrand; K. Desseaux; G. Bouguen; A. Bourreille; O. Dewit; C. Stefanescu; G. Vernier; E. Louis; J.C. Grimaud; B. Godart; G. Savoye; X. Hebuterne; P. Bauer; M. Nachury; D. Laharie; S. Chevret; Y. Bouhnik; G.Etud Thera Affections 2016 |
10.1093/ecco-jcc/jjv162 |
Five Functional Aspects of the Epidermal Barrier A. Lefevre-Utile; C. Braun; M. Haftek; F. Aubin 2021 |
10.3390/ijms222111676 |
Five simultaneous artificial intelligence data challenges on ultrasound, CT, and MRI N. Lssaua; T. Estienne; P. de Vonnecourt; M. Azoulay; J. Cagnol; G. Garcia; M. Majer; E. Jehanno; R. Renard-Penna; C. Balleyguier; F. Bidault; C. Caramella; T. Jacques; F. Dubrulle; J. Behr; N. Poussange; J. Bocquet; S. Montagne; F. Cornelis; M. Faruch; B. Bresson; S. Brunelle; A. Jalaguier-Coudray; N. Annoretti; A. Blum; A. Paisant; V. Herreros; O. Rouviere; S. Si-Mohamed; L. Di Marco; O. Hauger; M. Garetier; F. Pigneur; A. Bergere; C. Cyteval; L. Fournier; C. Malhaire; J.L. Drape; E. Poncelet; C. Bordonne; H. Cauliez; J.F. Budzik; M. Boisserie; T. Willaume; S. Moliere; P. Faure; C. Giurca; V. Juhan; T. Caramella; A. Perrey; F. Desmots; M. Faivre-Pierre; M. Abitbol; R. Lotte; D. Istrati; D. Guenoun; A. Luciani; M. Zins; J.F. Meder; A. Cotten 2019 |
10.1016/j.diii.2019.02.001 |
Five Ways in Which Computational Modeling Can Help Advance Cognitive Science: Lessons From Artificial Grammar Learning W. Zuidema; R.M. French; R.G. Alhama; K. Ellis; T.J. O'Donnell; T. Sainburg; T.Q. Gentner 2020 |
10.1111/tops.12474, Early Access Date = {OCT 2019 |
Five Ways in Which Computational Modeling Can Help Advance Cognitive Science: Lessons From Artificial Grammar Learning W. Zuidema; R.M. French; R.G. Alhama; K. Ellis; T.J. O'Donnell; T. Sainburg; T.Q. Gentner 2020 |
10.1111/tops.12474 |
Five-Year Clinical Outcome and Valve Durability After Transcatheter Aortic Valve Replacement in High-Risk Patients: FRANCE-2 Registry R. Didier; H. Eltchaninoff; P. Donzeau-Gouge; K. Chevreul; J. Fajadet; P. Leprince; A. Leguerrier; M. Lievre; A. Prat; E. Teiger; T. Lefevre; D. Tchetche; D. Carrie; D. Himbert; B. Albat; A. Cribier; A. Sudre; D. Blanchard; G. Rioufol; F. Collet; R. Houel; P.Dos Santos; N. Meneveau; S. Ghostine; T. Manigold; P. Guyon; T. Cuisset; H. Le Breton; S. Delepine; X. Favereau; G. Souteyrand; P. Ohlmann; V. Doisy; T. Lognone; A. Gommeaux; J.P. Claudel; F. Bourlon; B. Bertrand; B. Iung; M. Gilard 2018 |
10.1161/CIRCULATIONAHA.118.036866 |
Five-year follow-up data from the French national Copaxone observatory M. Clanet; A. Moulignier; C. Pierrot-Deseilligny; C. Lebrun-Frenay; T. Moreau; A. Leizorovicz; F. Boutitie; P.H. Depoortere; F. Gueyffier 2015 |
|
Five-year follow-up of the phase III study comparing SB3 (trastuzumab biosimilar) and reference trastuzumab in patients with HER2 positive early or locally advanced breast cancer X. Pivot; O. Burian; F. Bazan; M. Wojtukiewicz; H. Jang; S. Kim; J. Lee; Y.C. Yoon 2021 |
10.1016/j.annonc.2021.08.435 |
Five-Year Metabolic, Functional, and Safety Results of Patients With Type 1 Diabetes Transplanted With Allogenic Islets Within the Swiss-French GRAGIL Network S. Lablanche; S. Borot; A. Wojtusciszyn; F. Bayle; R. Tetaz; L. Badet; C. Thivolet; E. Morelon; L. Frimat; A. Penfomis; L. Kessler; C. Brault; C. Colin; I. Tauveron; D. Bosco; T. Berney; P.Y. Benhamou; G.R.A.G.I.L. Network 2015 |
10.2337/dc15-0094 |
Five-year outcome in the copaxone observatory: a nationwide cohort of patients with multiple sclerosis starting treatment with glatiramer acetate in France C. Lebrun-Frenay; A. Moulignier; C. Pierrot-Deseilligny; R. Benrabah; T. Moreau; C. Lubetzki; F. Monchecourt; H. Abboud; A. Samad; A. Abdulnayef; A. Khedr; H. Alchaar; J. Amevigbe; G. Angibaud; O. Anne; M.S. Artaud-Uriot; G. Ast; J. Augustin; M. Aupy; C. Azais-Vuillemin; M. Bailbe; P. Barbaste; P. Barres; A. Belhadia; R. Benrabah; O. Berets; F.X. Bergouignan; T. Bierme; F. Bille-Turc; S. Blanc; C. Boisselier; I. Bonnet; J.P. Borsotti; B. van Nieuwenhuyse; C. Bouchard; A. Bouchareine; G. Boudouresques; J.M. Boulesteix; P. Boulu; B. Bourghol; D. Brassat; A. Bredin; G. Breteau; W. Camu; B. Carlander; W. Casseron; G. Castelnovo; S. Chapuis; J.P. Chartier; G. Chauplannaz; F. Chaury; C. Cherlet; M. Clanet; P. Clavelou; F. Clerc; R. Colamarino; P. Contis; C. Couratier; M. Coustans; C. Crauser; N. Daluzeau; J.M. De Bray; T. de Broucker; V. de Burghgraeve; P. De Facq; J. De Seze; M. Debouverie; G. Defer; I. Degaey; S. Delassaux; J. Delorme; B. Denis; N. Derache-Belpame; O. Dereeper; S.A. Dereux; F. Derouiche; P. Devos; A.M. Deyrolle; J. Dib; M. Dib; M.C. Dourneau-Lethiecq; M. Doux; S. Dufourd-Delalande; M. Dujardin; A. Dunac; G. Durand; P. Dussaux; P. Eck; A. Engles; M.P. Feltin; A. Ferrier; M.C. Fleury; P. Gaida; O. Gal; A. Gayou-Joyeux; A. Gentil; G. Geraud; J. Gere; J.C. Getenet; C. Giannesini; E. Giraud; P. Giraud; P. Gras; G. Griffie; C. Gueganno-Roche; A.M. Guennoc; L. Guilloton; H. Guinot; C. Guiraud-Chaumeil; C. Guiziou; C. Gurau-Vasilescu; N. Guy-Renouil; J.B. Hamon; O. Heinzlef; C. Hemet-Francois; J.L. Henlin; P. Homeyer; P. Hourmant; J.P. Hurtevent; O. Ille; E. Josien; C. Juhel; M. Kalafat; S. Kelfa-Testut; A. Kopf; C.P. Kpade; M. Lalisse; D. Laplaud; J. Lapras; J.L. Larrieu; G. Lavernhe; A. Layet; A. Le Bayon; P. Le Coz; C. Lebrun-Frenay; J. Leche; A. Legout; P. Lejeune; P. Lemarquis; G. Level; J. Lizeretti; D. Locuratolo; M. Logak; P. Louchart; P. Louiset; M. Lubeau; A. Mackowiak; L. Magy; M. Maillet-Vioud; J. Mallecourt; C. Mallecourt; S. Marcel; I. Mari; P. Marrel; J. Maupetit; S. Medjbeur; D. Menard; P. Meynieu; M.C. Minot-Myhie; B. Montagne; T. Moreau; C. Moreau; A. Moulignier; P. Muh; J.B. Nkendjuo; A. Negre; P. Neuschwander; V. Neuville; A. Nibbio; J. Ollier; B. Ondze; J.C. Ouallet; N. Patte-Karsenti; J. Pelletier; P. Perrotte; D. Pez; C. Pierrot-Deseilligny; J.C. Pin; S. Pittion-Vouyovitch; C. Popescu; A. Poujois; A. Pouliquen; A. Pouyet; C. Remy; C. Renglewicz-Destuynder; G. Riche; L. Rieu; C. Robin; A. Robinson; N. Rosey-Dufosse; B. Roualdes; M.H. Rougie; F. Rouhart; I. Ruggieri; S. Saad; J. Saintarailles; A.M. Salandini-Roque; M. Salzmann; N. Schmidt; J. Senant; T. Sergeant; V. Seyeux; J. Siboni; O. Simon; S.E. Sankari; G. Taurin; S. Thibault-Tanchou; J.N. Tillier; A. Tougeron; L. Toureille-Borlet; P. Tourniaire; H. Touzani; S. Trefouret; X. Vandamme; J. Vaunaize; F. Viala; U.C. Viola; J.M. Visy; M. Vlaicu-Bustuchina; F. Vuillemet; V. Wattier; A. Wavreille; K. Wegener; S. Wiertlewski; C. Zaenker; H. Zephir-Thi; F. Ziegler; C. Observ 2019 |
10.1007/s00415-019-09211-5 |
FIVE-YEAR OUTCOMES AFTER RANDOMIZED TREATMENT BY RITUXIMAB IN EARLY ACUTE ANTIBODY-MEDIATED REJECTION IN RENAL TRANSPLANTATION - LONG TERM OUTCOMES OF THE RITUX ERAH STUDY E. Bailly; G. Blancho; S. Ville; E. Morelon; J. Bamoulid; S. Caillard; V. Chatelet; P. Malvezzi; J. Tourret; V. Vuiblet; D. Anglicheau; D. Bertrand; P. Grimbert; F. Haidar; M. Hazzan; N. Kamar; P. Merville; C. Mousson; V. Pernin; C. Pouteil-Noble; R. Purgus; J. Sayegh; P.F. Westeel; M. Buchler 2018 |
|
Five-Year Outcomes after Randomized Treatment by Rituximab in Early Acute Antibody-Mediated Rejection in Renal Transplantation: Long Term Outcomes of the RITUX ERAH Study. E. Bailly; G. Blancho; S. Ville; E. Morelon; J. Bamoulid; S. Caillard; V. Chatelet; P. Malvezzi; J. Tourret; V. Vuiblet; D. Anglicheau; D. Bertrand; P. Grimbert; F. Haidar; M. Hazzan; N. Kamar; P. Merville; C. Mousson; V. Pernin; C. Pouteil-Noble; R. Purgus; J. Sayegh; P. Westeel; M. Buchler 2018 |
|
Five-year outcomes following timely primary percutaneous intervention, late primary percutaneous intervention, or a pharmaco-invasive strategy in ST-segment elevation myocardial infarction: the FAST-MI programme N. Danchin; B. Popovic; E. Puymirat; P. Goldstein; L. Belle; G. Cayla; F. Roubille; G. Lemesle; J. Ferrieres; F. Schiele; T. Simon; F.A.S.T.M.I. Investigators 2020 |
10.1093/eurheartj/ehz665 |
Five-Year Outcomes From the Randomized, Phase 3 Trials CheckMate 017/057: Nivolumab vs Docetaxel in Previously Treated NSCLC S. Gettinger; H. Borghaei; J. Brahmer; L. Chow; M. Burgio; D.Castro Carpeno; A. Pluzanski; O. Arrieta; A. Frontera; R. Chiari; C. Butts; J. Wojcik-Tomaszewska; B. Coudert; M. Garassino; N. Ready; E. Felip; A. Garcia; D. Waterhouse; M. Domine; F. Barlesi; S. Antonia; M. Wohlleber; D. Gerber; G. Czyzewicz; D. Spigel; L. Crino; W. Eberhardt; A. Li; S. Marimuthu; E. Vokes 2019 |
10.1016/j.jtho.2019.08.486 |
Five-year outcomes from the randomized, phase 3 trials CheckMate 017/057: nivolumab vs docetaxel in previously treated NSCLC M. Lind; S. Gettinger; H. Borghaei; J. Brahmer; L. Chow; M. Burgio; D.Castro Carpeno; A. Pluzanski; O. Arrieta; A. Frontera; R. Chiari; C. Butts; J. Wojcik-Tomaszewska; B. Coudert; M. Garassino; N. Ready; E. Felip; A. Garcia; D. Waterhouse; M. Domine; F. Barlesi; S. Antonia; M. Wohlleber; D. Gerber; G. Czyzewicz; D. Spigel; L. Crino; W. Eberhardt; A. Li; S. Marimuthu; E. Vokes 2020 |
|
Five-Year Outcomes From the Randomized, Phase III Trials CheckMate 017 and 057: Nivolumab Versus Docetaxel in Previously Treated Non-Small-Cell Lung Cancer H. Borghaei; S. Gettinger; E.E. Vokes; L.Q.M. Chow; M.Angelo Burgio; Jde Castro Carpeno; A. Pluzanski; O. Arrieta; O.Aren Frontera; R. Chiari; C. Butts; J. Wojcik-Tomaszewska; B. Coudert; M.Chiara Garassino; N. Ready; E. Felip; M.Alonso Garcia; D. Waterhouse; M. Domine; F. Barlesi; S. Antonia; M. Wohlleber; D.E. Gerber; G. Czyzewicz; D.R. Spigel; L. Crino; W.Enst Erich Eberhardt; A. Li; S. Marimuthu; J. Brahmer 2021 |
10.1200/JCO.20.01605 |
Five-Year Survival in Patients With ST-Segment-Elevation Myocardial Infarction According to Modalities of Reperfusion Therapy The French Registry on Acute ST-Elevation and Non-ST-Elevation Myocardial Infarction (FAST-MI) 2005 Cohort N. Danchin; E. Puymirat; P.Gabriel Steg; P. Goldstein; F. Schiele; L. Belle; J. Fajadet; K. Khalife; P. Coste; J. Ferrieres; T. Simon; F.A.S.T.M.I.2005 Investigators 2014 |
10.1161/CIRCULATIONAHA.113.005874 |